about
A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitisA DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy.Male genital representation in paleolithic art: erection and circumcision before history.Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trialVirtual reality simulator for training on photoselective vaporization of the prostate with 980 nm diode laser and learning curve of the technique.Hypofractionated radiation therapy versus conventional radiation therapy in prostate cancer: A systematic review of its safety and efficacy.Laser transurethral resection of the prostate: Safety study of a novel system of photoselective vaporization with high power diode laser in prostates larger than 80mL.High-dose rate brachytherapy as monotherapy in prostate cancer: A systematic review of its safety and efficacy.The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.Trends in the management of urolithiasis in Latin America, Spain and Portugal: results of a survey in the Confederación Americana de Urología (CAU).Urothelial carcinoma of the prostate.Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms).Surgical management of renal cell cancer with tumor thrombus through an exclusive transabdominal approach.The study of DNA methylation in urological cancer: present and future.Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder.Expert consensus on scientific evidence available on the use of botulinum toxin in overactive bladder.Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.Extended-spectrum beta-lactamases in urinary tract infections caused by Enterobacteria: understanding and guidelines for action.The normal and pathologic renal medulla: a comprehensive overview.Miniperc and retrograde intrarenal surgery: when and how?Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Efficacy of low-intensity shock wave therapy for erectile dysfunction: A systematic review and meta-analysis.Wine polyphenols exert antineoplasic effect on androgen resistant PC-3 cell line through the inhibition of the transcriptional activity of COX-2 promoter mediated by NF-kβ.Survey on graduate education in the Confederación Americana de Urología: Opinions and reality.Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.Comparative study of the B-SAQ, OAB-V8 and OAB-V3 questionnaires as screening tools for overactive bladders in clinical practice.Treatment of long anterior urethral stricture associated to lichen sclerosus.EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.Comparative study of multiport laparoscopy and umbilical laparoendoscopic single-site surgery with reusable platform for treating renal masses.Prospective study comparing laparoscopic and open adenomectomy: Surgical and functional results.Commentary to low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model, published in J Sex Med 2016;13:22-32 by Li H, Matheu P, Sun F, et al.Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective.Revealing the production process of Joaquín Albarrán's Les Tumeurs de la Vessie 125 years after its writing.Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapy.Interobserver consistency of digital rectal examination in clinical staging of localized prostatic carcinoma.Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.
P50
Q27002215-EAA3CD15-2F83-462E-AA04-C02FA9BADB79Q34528087-ECD4299F-105F-47CC-8C9C-57FEE81E8800Q34606921-A5E8ED45-6615-41DE-871F-DB929BEDF325Q34991783-35239AFA-8274-46B6-B110-3859C699B235Q35139891-A81355BE-6D78-4455-81F0-8F1A5AD6E592Q35557465-60230CC0-B070-47DA-B7CF-E4061D09A7FDQ35572659-511354AB-6720-4020-9DC9-B4BB8A4B2E9AQ36096666-46E40E3B-BECF-4032-A759-09A596479801Q36235826-91F8536C-C3A5-4AA0-B873-171BDEE6A431Q36394422-3375EC87-9B8E-4F19-99A1-BD2BF2D74B54Q36729140-E84A1359-EFCA-4EFE-B106-3908C531BEAFQ37119868-BA9EE4AF-9A9C-430B-A5CC-52103117F00FQ37599059-AA9A4FCB-002F-4590-AC93-0A01B3D313E4Q37866593-6ED279C6-9FDB-4D48-A51B-3C063A23BCF6Q38104113-788042B8-84EB-41FD-AA2C-99524585B82DQ38121331-2CCDE111-1355-44F5-8962-464C01FBC33AQ38179575-19CD8C60-EC66-45BE-9290-F9393B88557EQ38190923-0B8BA360-6DB5-4887-B21B-85DC46D883C4Q38225277-AFB481B3-97A1-48B3-A9B4-68363B653DA8Q38321565-3D992AF8-3C29-4399-AB38-18F8B88779C1Q38351522-731431C3-74ED-4ACA-978B-6F14E7C0056BQ38352217-9512B341-7741-40C4-A9FC-23982B193AB8Q38453864-4943E87F-D874-453A-8EE2-260A032511C0Q38460729-82D68A02-22FB-49AB-A71B-CD3BB758769BQ38833395-630CFAAE-DE89-4D2C-9EB9-7F3C00C56FDDQ38926739-F59CB515-33DE-435D-8063-EDD0F70F4B1CQ38994222-389E0489-C10F-4141-A529-E2D63AE49FB4Q39017370-E65E60A7-B484-446D-B194-5F30AC5D8400Q39089770-BC05BE09-9E33-4EDB-9C5D-20C19C6027ACQ39166454-987C1499-76F5-4B84-A773-C510A80DDDEFQ39212942-F4ABE8B0-2F7B-4C95-B2B0-776AEFBE10AEQ39372010-B984D371-FDAF-4FA2-A9E6-38EFB208264AQ39640694-01626E00-96C7-46AE-89F3-83CF44280F18Q39746607-144D5645-C36D-4C88-8FEC-03827915832BQ39790256-3E811765-ADBE-4EAA-BB34-C001643E5107Q39911295-0B83A948-C8A4-49D9-8BD1-BF94B842A8B6Q39947197-59713EC8-E70E-4BB6-AE71-B5B58862DA30Q39963222-43AEF9D0-DAD2-4F99-AB2D-418EA08F4778Q39966178-0B1973A9-4D1D-48AF-8774-E32A927BC2E8Q40053362-44B41C5C-F2B9-4BBF-88A9-35899F6ABBDF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Javier C. Angulo
@ast
Javier C. Angulo
@en
Javier C. Angulo
@es
Javier C. Angulo
@nl
Javier C. Angulo
@sl
type
label
Javier C. Angulo
@ast
Javier C. Angulo
@en
Javier C. Angulo
@es
Javier C. Angulo
@nl
Javier C. Angulo
@sl
prefLabel
Javier C. Angulo
@ast
Javier C. Angulo
@en
Javier C. Angulo
@es
Javier C. Angulo
@nl
Javier C. Angulo
@sl
P106
P1153
35902420600
P21
P31
P496
0000-0002-1735-8792